The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| APELLIS PHARMACEUTICALS INC | Common | 03753U106 | 8,123,963 | 123,165 | SH | SOLE | 123,165 | 0 | 0 | |||
| ARCUTIS BIOTHERAPEUTICS INC | Common | 03969K108 | 1,960,387 | 178,217 | SH | SOLE | 178,217 | 0 | 0 | |||
| ASCENDIS PHARMA A/S - ADR | Sponsored ADR | 04351P101 | 8,278,456 | 77,210 | SH | SOLE | 77,210 | 0 | 0 | |||
| ASTRIA THERAPEUTICS INC | Common | 04635X102 | 1,347,809 | 101,339 | SH | SOLE | 101,339 | 0 | 0 | |||
| BIOCRYST PHARMACEUTICALS INC | Common | 09058V103 | 9,703,882 | 1,163,535 | SH | SOLE | 1,163,535 | 0 | 0 | |||
| BIOGEN INC(NSM) | Common | 09062X103 | 10,414,726 | 37,459 | SH | SOLE | 37,459 | 0 | 0 | |||
| CYMABAY THERAPEUTICS INC | Common | 23257D103 | 14,208,926 | 1,629,464 | SH | SOLE | 1,629,464 | 0 | 0 | |||
| CRINETICS PHARMACEUTICALS IN | Common | 22663K107 | 11,901,151 | 741,043 | SH | SOLE | 741,043 | 0 | 0 | |||
| CYTOKINETICS INC | Common | 23282W605 | 9,954,758 | 282,886 | SH | SOLE | 282,886 | 0 | 0 | |||
| AMICUS THERAPEUTICS INC(NMS) | Common | 03152W109 | 2,864,414 | 258,288 | SH | SOLE | 258,288 | 0 | 0 | |||
| HORIZON THERAPEUTICS PLC | SHS | G46188101 | 10,828,543 | 99,217 | SH | SOLE | 99,217 | 0 | 0 | |||
| ITEOS THERAPEUTICS INC | Common | 46565G104 | 6,541,687 | 480,653 | SH | SOLE | 480,653 | 0 | 0 | |||
| KALVISTA PHARMACEUTICALS INC | Common | 483497103 | 8,818,779 | 1,121,982 | SH | SOLE | 1,121,982 | 0 | 0 | |||
| CHINOOK THERAPEUTICS INC | Common | 16961L106 | 11,732,837 | 506,818 | SH | SOLE | 506,818 | 0 | 0 | |||
| MORPHIC HOLDING INC | Common | 61775R105 | 9,282,626 | 246,616 | SH | SOLE | 246,616 | 0 | 0 | |||
| SAGE THERAPEUTICS INC | Common | 78667J108 | 6,084,955 | 145,018 | SH | SOLE | 145,018 | 0 | 0 | |||
| SCILEX HOLDING CO(NAS) | Common | 80880W106 | 85,198 | 10,390 | SH | SOLE | 10,390 | 0 | 0 | |||
| 2SEVENTY BIO INC | Common | 901384107 | 1,756,318 | 172,188 | SH | SOLE | 172,188 | 0 | 0 | |||